Alopecia drugs

Comment

Author: Admin | 2025-04-28

T, et al. (Updated 2024). Minoxidil. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK482378/Bistas, et al. (Updated 2024). Finasteride. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK513329/FDA Drug Safety Communication: 5-alpha reductase inhibitors (5-ARIs) may increase the risk of a more serious form of prostate cancer. Retrieved from https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-5-alpha-reductase-inhibitors-5-aris-may-increase-risk-more-seriousHo CH, et al. (Updated 2024). Androgenetic Alopecia. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK430924/Hu R, et al. (2015). ​​Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients. https://onlinelibrary.wiley.com/doi/abs/10.1111/dth.12246Hughes EC, et al. (Updated 2024). Telogen Effluvium. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK430848/Kaufman KD, et al. (1998). Finasteride in the treatment of men with androgenetic alopecia. Retrieved from https://pubmed.ncbi.nlm.nih.gov/9777765/Lepe K, et al. (Updated 2024). Alopecia Areata. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK537000/PROPECIA® (finasteride) tablets for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020s021s023lbl.pdfShapiro J, et al. (2015). Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss). Retrieved from https://www.sciencedirect.com/science/article/pii/S0022202X15529357Yanagisawa M, et al. (2019). Long-term (10-year) efficacy of finasteride in 523 Japanese men with androgenetic alopecia. Retrieved from https://www.researchgate.net/publication/337105943_Long-term_10-year_efficacy_of_finasteride_in_523_Japanese_men_with_androgenetic_alopeciaEditorial StandardsHims & Hers has strict sourcing guidelines to ensure our content is accurate and current. We rely on peer-reviewed studies, academic research institutions, and medical associations. We strive to use primary sources and refrain from using tertiary references. See a mistake? Let us know at [email protected]!

Add Comment